Mesoblast Limited (Nasdaq:MESO; ASX:MSB), a world leader in developing allogeneic (off-the-shelf) cellular medicines, just announced that the first COVID-19 infected …
Personalized medicine has become a paradigm-shifting trend in healthcare - the hegemony of “one-size-fits-all” drugs is increasingly challenged by novel innovative …
The world’s largest online global summit dedicated to AI in medicine where clinicians, technologists, NGO’s and c-suite executives from all …
Read more ›››
This website uses cookies
We use cookies to personalise content and to analyse our traffic. We also share information about your use of our site
with our analytics partners who may combine it with other information that you’ve provided to them or that they’ve collected
from your use of their services. You consent to our cookies if you continue to use our website. Read more details in our
cookies policy.